BRPI1014081A2 - uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma - Google Patents
uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesmaInfo
- Publication number
- BRPI1014081A2 BRPI1014081A2 BRPI1014081A BRPI1014081A BRPI1014081A2 BR PI1014081 A2 BRPI1014081 A2 BR PI1014081A2 BR PI1014081 A BRPI1014081 A BR PI1014081A BR PI1014081 A BRPI1014081 A BR PI1014081A BR PI1014081 A2 BRPI1014081 A2 BR PI1014081A2
- Authority
- BR
- Brazil
- Prior art keywords
- bacterium
- mixture
- bifidobacterium animalis
- lactis strain
- animalis subsp
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title 1
- 241001134770 Bifidobacterium animalis Species 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21856309P | 2009-06-19 | 2009-06-19 | |
PCT/IB2010/052757 WO2010146568A2 (en) | 2009-06-19 | 2010-06-18 | Bifidobacteria for treating diabetes and related conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1014081A2 true BRPI1014081A2 (pt) | 2016-04-19 |
Family
ID=42989263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1014081A BRPI1014081A2 (pt) | 2009-06-19 | 2010-06-18 | uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma |
Country Status (8)
Country | Link |
---|---|
US (7) | US20120107291A1 (pt) |
EP (3) | EP2442814B1 (pt) |
CN (5) | CN104770739A (pt) |
BR (1) | BRPI1014081A2 (pt) |
DK (3) | DK2808024T3 (pt) |
ES (3) | ES2763137T3 (pt) |
PL (3) | PL2808024T3 (pt) |
WO (1) | WO2010146568A2 (pt) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102670661B (zh) * | 2011-03-08 | 2013-10-02 | 惠宏襄 | 用于刺激胰高血糖素样肽-1分泌的药物 |
ITMI20111488A1 (it) | 2011-08-03 | 2013-02-04 | Gnosis Spa | Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita' |
CN103082292B (zh) * | 2011-11-02 | 2015-03-04 | 深圳华大基因研究院 | 罗斯氏菌(Roseburia)在治疗和预防肥胖相关疾病中的应用 |
CN110201003A (zh) | 2012-02-29 | 2019-09-06 | 伊西康内外科公司 | 微生物区系的组合物及与其相关的方法 |
CN102792919B (zh) * | 2012-08-08 | 2015-09-09 | 上海交通大学 | 悉生动物肥胖模型的构建方法及其应用 |
CA2884281C (en) * | 2012-09-11 | 2021-01-05 | Thylabisco Ab | Prebiotic thylakoid composition |
CN104968780A (zh) * | 2012-09-20 | 2015-10-07 | 普洛特拉有限公司 | 用于治疗肥胖和肥胖相关病症的益生菌组合物和方法 |
BR112015014693A2 (pt) * | 2012-12-20 | 2017-10-10 | Gervais Danone Sa | uso de bifidobacterium animalis para o tratamento ou a prevenção de ganho de peso corpóreo e resistência à insulina |
ES2526986B1 (es) | 2013-07-18 | 2015-11-02 | Biopolis, S.L. | Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas |
US10633714B2 (en) | 2013-07-21 | 2020-04-28 | Pendulum Therapeutics, Inc. | Methods and systems for microbiome characterization, monitoring and treatment |
CA2926466C (en) * | 2013-10-03 | 2021-11-16 | Frederic Bushman | Compositions comprising a defined microbiome and methods of use thereof |
US10058576B2 (en) | 2013-10-03 | 2018-08-28 | The Trustees Of The University Of Pennsylvania | Compositions and methods comprising a defined microbiome and methods of use thereof |
BE1000016B1 (fr) * | 2014-04-25 | 2016-02-01 | Vesale Pharma Nv | Composition comprenant du bifidobacterium animalis ssp. lactis. |
CN106535908A (zh) * | 2014-02-14 | 2017-03-22 | 凡赛尔医药股份有限公司 | 包括动物双歧杆菌亚种乳酸菌lmg p‑28149的组合物 |
WO2015121455A1 (fr) * | 2014-02-14 | 2015-08-20 | Vesale Pharma Sa | Composition comprenant au moins un probiotique |
WO2015121458A2 (fr) * | 2014-02-14 | 2015-08-20 | Vesale Pharma Sa | Composition comprenant du bifidobacterium animalis ssp. lactis |
BE1000017B1 (fr) * | 2014-04-25 | 2016-01-21 | Vesale Pharma Nv | Composition comprenant au moins un probiotique |
WO2016020486A1 (en) * | 2014-08-08 | 2016-02-11 | Nestec S.A. | A combination of myo-inositol and zinc and its use |
ES2858507T3 (es) * | 2014-08-08 | 2021-09-30 | Nestle Sa | Combinación de vitamina D con cinc y su uso |
TWI572713B (zh) * | 2014-10-31 | 2017-03-01 | 豐華生物科技股份有限公司 | 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用 |
SG10201903823QA (en) | 2014-10-31 | 2019-05-30 | Whole Biome Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
CN107405321A (zh) | 2015-01-23 | 2017-11-28 | 坦普尔大学 | 短链脂肪酸在癌症预防中的应用 |
GB201514303D0 (en) * | 2015-07-16 | 2015-09-23 | Dupont Nutrition Biosci Aps | Bifidobacteria for treating cardiac conditions |
GB201514302D0 (en) * | 2015-07-16 | 2015-09-23 | Dupont Nutrition Biosci Aps | Lactobacilli for treating cardiac dysfunction |
US9980491B2 (en) * | 2015-07-25 | 2018-05-29 | Siobhan Reilly | Probiotic compositions and methods of use |
EP3173085A1 (en) * | 2015-11-30 | 2017-05-31 | Vaiomer | Polydextrose for the prevention and/or treatment of heart failure |
CN105770892A (zh) * | 2016-02-04 | 2016-07-20 | 烟台金海药业有限公司 | 一种防治鸡心包积液-肝炎综合征生物兽药的制备方法 |
CN105797156A (zh) * | 2016-03-15 | 2016-07-27 | 烟台金海药业有限公司 | 一种防治hhs的抗原抗体复合物制剂的制备方法 |
CN107224584A (zh) * | 2016-03-25 | 2017-10-03 | 上海来益生物药物研究开发中心有限责任公司 | 一种益生菌组合物及其应用 |
BR112018070518A2 (pt) * | 2016-04-14 | 2019-01-29 | Dupont Nutrition Biosci Aps | bactéria do gênero bifidobacterium, usos de uma bactéria do gênero bifidobacterium e método para reduzir a ingestão de alimentos, energia e/ou gordura |
EP3442549B1 (en) * | 2016-04-14 | 2024-03-20 | International N&H Denmark ApS | Bifidobacteria for increasing lean body mass |
JP6986856B2 (ja) * | 2016-05-10 | 2021-12-22 | 協同乳業株式会社 | トリメチルアミンを産生し難い腸内菌叢を形成するためのプロバイオティクス組成物および方法 |
CN106619742A (zh) * | 2016-11-08 | 2017-05-10 | 江西益盟科技有限公司 | 治疗糖尿病的乳酸菌组合物及其制备方法 |
EP3551202B1 (en) * | 2016-12-06 | 2024-01-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of enhancing the potency of incretin-based drugs in subjects in need thereof |
AU2018216532B2 (en) * | 2017-01-31 | 2021-06-03 | Navipharm Co, Ltd | Novel lactic acid bacteria and use thereof |
MY197201A (en) * | 2017-02-10 | 2023-05-31 | Perfect China Co Ltd | Novel probiotics bifidobacteria strains |
CN106617096B (zh) * | 2017-02-15 | 2020-12-18 | 中国农业大学 | 一种增强胰岛功能的双歧杆菌及其应用 |
CN107050065B (zh) * | 2017-03-31 | 2021-03-30 | 杭州远大生物制药有限公司 | 双歧四联活菌组合物的新应用 |
CN107410486A (zh) * | 2017-06-27 | 2017-12-01 | 合肥工业大学 | 一种降血糖玫瑰茄发酵乳的制备方法 |
EP3645024B1 (en) * | 2017-06-30 | 2022-09-14 | N.V. Nutricia | Synbiotic composition for preventing fatty liver disease |
US11389487B2 (en) * | 2017-08-06 | 2022-07-19 | Second Genome, Inc. | Streptococcus australis as a biotherapeutic |
WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
CN107723257A (zh) * | 2017-09-20 | 2018-02-23 | 深圳市晨光乳业有限公司 | 一种动物双歧杆菌及其食品组合物 |
US11344584B2 (en) * | 2017-09-26 | 2022-05-31 | Second Genome, Inc. | Gemella sanguinis as a biotherapeutic |
EP3704958A4 (en) * | 2017-10-31 | 2021-06-30 | Morinaga Milk Industry Co., Ltd. | COMPOSITION FOR INCREASING MUSCLE MASS |
WO2019084617A1 (en) * | 2017-11-01 | 2019-05-09 | Medlab Ip Pty Ltd | Modulation of intestinal microbiota in pre-diabetes and type 2 diabetes |
US20210177031A1 (en) * | 2017-11-09 | 2021-06-17 | Societe Des Produits Nestle S.A. | An array of age-tailored nutritional formula for infants and young children for use in the prevention of sub-optimal body composition |
JP7266580B2 (ja) * | 2018-03-23 | 2023-04-28 | 森永乳業株式会社 | 学童期以降の高血糖に起因する疾患の予防のための乳幼児用組成物 |
CN109259243A (zh) * | 2018-09-26 | 2019-01-25 | 广州普维君健药业有限公司 | 降三高的组合物及其制备方法和应用 |
CN109486715B (zh) * | 2018-12-07 | 2022-07-15 | 江苏靶标生物医药研究所有限公司 | 一种富硒长双歧杆菌及其制备方法和应用 |
WO2020113579A1 (zh) * | 2018-12-07 | 2020-06-11 | 深圳华大生命科学研究院 | 单形巨单胞菌在预防和/或治疗代谢性疾病中的用途 |
CN109998113A (zh) * | 2019-04-18 | 2019-07-12 | 广东省微生物研究所(广东省微生物分析检测中心) | 一种具有降血糖功效的益生菌制剂的功能性食品 |
CN110150669B (zh) * | 2019-04-29 | 2022-09-06 | 河北一然生物科技股份有限公司 | 一种适于糖尿病患者食用的益生菌组合物及其应用 |
US20220249582A1 (en) * | 2019-05-30 | 2022-08-11 | University College Cork - National University Of Ireland, Cork | Gaba-producing culturable bacteria and use for improving health |
CN110604749B (zh) * | 2019-08-30 | 2020-08-14 | 北京农学院 | 动物双歧杆菌a12及其在控制糖尿病或高血脂症特别是体重增加或肥胖中的应用 |
US11638726B2 (en) | 2019-09-25 | 2023-05-02 | Tall Goods Llc | Methods for producing probiotics fortified avian eggs and egg products and formulations thereof |
CN113197313B (zh) * | 2020-09-02 | 2023-10-27 | 内蒙古蒙牛乳业(集团)股份有限公司 | 具有改善胰岛素抵抗及空腹血糖的益生菌组合物及制备方法 |
US11896581B2 (en) | 2020-09-04 | 2024-02-13 | Société des Produits Nestlé S.A. | Compositions and methods for providing health benefits in an animal |
CN113207961B (zh) * | 2020-09-29 | 2023-06-23 | 内蒙古蒙牛乳业(集团)股份有限公司 | 乳双歧杆菌MN-Gup乳制品及其在改善2型糖尿病中应用 |
CN112535275A (zh) * | 2020-12-10 | 2021-03-23 | 淮北师范大学 | 一种具有α-葡萄糖苷酶抑制活性的发酵菊花凉拌酱的制备方法 |
CN113215030B (zh) * | 2021-04-12 | 2022-10-25 | 天津中医药大学 | 约氏乳杆菌eu03及其用途 |
CN113249264B (zh) * | 2021-06-03 | 2021-11-23 | 北京量化健康科技有限公司 | 一株青春双歧杆菌及其在代谢综合征中的应用 |
CN113678979A (zh) * | 2021-08-25 | 2021-11-23 | 上海英库商务咨询有限公司 | 用于促使ii型糖尿病人群胰岛素合成和分泌的固体饮料 |
CN113995720B (zh) * | 2021-11-15 | 2023-03-17 | 郑州大学 | 一种乳剂包被型益生菌制剂及其制备方法与应用 |
CN115466689B (zh) * | 2022-02-09 | 2023-06-16 | 中国科学技术大学 | 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用 |
CN115281345A (zh) * | 2022-04-06 | 2022-11-04 | 金华银河生物科技有限公司 | 一种复合益生菌组合物联合二甲基胍治疗ⅱ型糖尿病的用途 |
WO2023219460A1 (ko) * | 2022-05-12 | 2023-11-16 | 주식회사 지아이바이옴 | 락토바실러스 퍼멘텀 균주 및 대사조절제를 포함하는 병용 요법을 이용한 대사질환 예방 또는 치료용 조성물 |
CN115948273B (zh) * | 2022-06-21 | 2023-07-18 | 合肥瀚微生物科技有限公司 | 治疗糖尿病及相关病症的两歧双歧杆菌 |
CN115137757A (zh) * | 2022-07-29 | 2022-10-04 | 承葛健康科技(广东)有限公司 | 一种辅助降血糖的益生菌组合物 |
CN117187145A (zh) * | 2023-10-20 | 2023-12-08 | 深圳保时健生物工程有限公司 | 一株具有降脂、降血糖和减重功能的嗜酸乳杆菌goldgut-la100及其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2002003A (en) | 1930-09-20 | 1935-05-21 | Ig Farbenindustrie Ag | Production of acetylene and carbon black |
JP2779963B2 (ja) * | 1989-02-09 | 1998-07-23 | 株式会社林原生物化学研究所 | ビフィズス菌増殖促進剤 |
SE510753C2 (sv) * | 1997-08-05 | 1999-06-21 | Probi Ab | Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod |
US6811786B1 (en) * | 1999-04-01 | 2004-11-02 | Ganeden Biotech, Inc. | Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions |
JP4580542B2 (ja) * | 2000-05-17 | 2010-11-17 | 株式會社バイオニア | 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物 |
SE0004124D0 (sv) | 2000-11-10 | 2000-11-10 | Probi Ab | New use |
US20030092163A1 (en) * | 2001-07-26 | 2003-05-15 | Collins John Kevin | Probiotic bifidobacterium strains |
US6953574B2 (en) * | 2002-06-21 | 2005-10-11 | Technology Commercialization, Inc. | Method for producing a fermented hydrolyzed medium containing microorganisms |
KR100527103B1 (ko) * | 2003-02-04 | 2005-11-09 | 최현우 | 지질대사개선효능을 갖는 미생물을 함유한 성인병 예방 및치료용 조성물 및 이의 용도 |
EP2805625B2 (en) * | 2005-02-28 | 2022-11-23 | N.V. Nutricia | Nutritional composition with prebiotics and probiotics |
SE529185C2 (sv) | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
EP1983849B1 (en) * | 2006-01-20 | 2013-04-03 | Innova Food AB | A food composition comprising amino acids |
KR101108428B1 (ko) | 2006-08-04 | 2012-01-31 | (주)바이오니아 | 인간의 모유에서 분리한 프로바이오틱 활성 및 체중 증가억제 효과를 갖는 유산균 |
CN101310606A (zh) * | 2007-05-24 | 2008-11-26 | 大连森佰澳科技有限公司 | 含有双歧杆菌功能信号分子和益生元的液体奶制品 |
EP2011506A1 (en) | 2007-07-05 | 2009-01-07 | Nestec S.A. | Supplementation of maternal diet |
EP2022502A1 (en) | 2007-08-10 | 2009-02-11 | Nestec S.A. | Lactobacillus rhamnosus and weight control |
EP2030623A1 (en) | 2007-08-17 | 2009-03-04 | Nestec S.A. | Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
US20110189149A1 (en) * | 2008-06-20 | 2011-08-04 | Remy Burcelin | New Uses of Lactic Acid Bacteria and Bifidobacteria |
-
2010
- 2010-06-18 EP EP10730548.4A patent/EP2442814B1/en active Active
- 2010-06-18 DK DK14179491.7T patent/DK2808024T3/da active
- 2010-06-18 CN CN201510184445.4A patent/CN104770739A/zh active Pending
- 2010-06-18 WO PCT/IB2010/052757 patent/WO2010146568A2/en active Application Filing
- 2010-06-18 PL PL14179491T patent/PL2808024T3/pl unknown
- 2010-06-18 PL PL17155654T patent/PL3181134T3/pl unknown
- 2010-06-18 ES ES17155654T patent/ES2763137T3/es active Active
- 2010-06-18 DK DK17155654.1T patent/DK3181134T3/da active
- 2010-06-18 ES ES14179491T patent/ES2729765T3/es active Active
- 2010-06-18 DK DK10730548.4T patent/DK2442814T3/en active
- 2010-06-18 BR BRPI1014081A patent/BRPI1014081A2/pt not_active Application Discontinuation
- 2010-06-18 EP EP14179491.7A patent/EP2808024B1/en active Active
- 2010-06-18 CN CN201510184444.XA patent/CN104784219A/zh active Pending
- 2010-06-18 EP EP17155654.1A patent/EP3181134B1/en active Active
- 2010-06-18 CN CN201080027390.1A patent/CN102458415B/zh active Active
- 2010-06-18 ES ES10730548T patent/ES2702977T3/es active Active
- 2010-06-18 US US13/377,325 patent/US20120107291A1/en not_active Abandoned
- 2010-06-18 CN CN201510184448.8A patent/CN104784220A/zh active Pending
- 2010-06-18 CN CN201510185083.0A patent/CN104784694A/zh active Pending
- 2010-06-18 PL PL10730548T patent/PL2442814T3/pl unknown
-
2014
- 2014-08-08 US US14/455,840 patent/US20140348796A1/en not_active Abandoned
-
2017
- 2017-03-07 US US15/452,240 patent/US20180021391A1/en not_active Abandoned
-
2018
- 2018-12-06 US US16/211,743 patent/US20190307815A1/en not_active Abandoned
-
2020
- 2020-02-24 US US16/798,831 patent/US20200316144A1/en not_active Abandoned
-
2021
- 2021-02-19 US US17/180,028 patent/US20210322491A1/en not_active Abandoned
-
2022
- 2022-09-12 US US17/942,700 patent/US20230248786A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2442814B1 (en) | 2018-09-26 |
US20190307815A1 (en) | 2019-10-10 |
US20210322491A1 (en) | 2021-10-21 |
ES2763137T3 (es) | 2020-05-27 |
ES2729765T3 (es) | 2019-11-06 |
WO2010146568A2 (en) | 2010-12-23 |
US20180021391A1 (en) | 2018-01-25 |
DK2442814T3 (en) | 2019-01-14 |
ES2702977T3 (es) | 2019-03-06 |
CN104784220A (zh) | 2015-07-22 |
PL2442814T3 (pl) | 2019-04-30 |
US20140348796A1 (en) | 2014-11-27 |
DK2808024T3 (da) | 2019-06-11 |
US20230248786A1 (en) | 2023-08-10 |
CN104770739A (zh) | 2015-07-15 |
PL3181134T3 (pl) | 2020-04-30 |
PL2808024T3 (pl) | 2019-09-30 |
EP2442814A2 (en) | 2012-04-25 |
CN102458415A (zh) | 2012-05-16 |
CN104784219A (zh) | 2015-07-22 |
EP2808024A1 (en) | 2014-12-03 |
US20200316144A1 (en) | 2020-10-08 |
EP3181134A1 (en) | 2017-06-21 |
EP3181134B1 (en) | 2019-10-30 |
US20120107291A1 (en) | 2012-05-03 |
DK3181134T3 (da) | 2020-01-20 |
CN104784694A (zh) | 2015-07-22 |
EP2808024B1 (en) | 2019-04-24 |
WO2010146568A3 (en) | 2011-05-05 |
CN102458415B (zh) | 2015-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1014081A2 (pt) | uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma | |
HK1226100B (zh) | 雙歧桿菌乳酸亞種(bifidobacterium animalis subsp.lactis)cect 8145的新菌株及其用於治療和/或預防超重和肥胖症以及相關疾病的用途 | |
DK2318513T3 (da) | Ny probiotisk bifidobacterium longum | |
GB2460781B (en) | Probiotic bifidobacterium strains | |
GB2465051B (en) | Probiotic bifidobacterium strains | |
ATE537707T1 (de) | Lactobacillus paracasei und gewichtskontrolle | |
DK2657333T3 (da) | Porcint circovirus type 2, immunsammensætning indeholdende samme, assaykit og anvendelse deraf | |
DE602006010723D1 (de) | Neues bakterium der gattung bifidobacterium und dessen nutzung | |
CL2012003026A1 (es) | Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad. | |
PT2626076T (pt) | Utilizações terapêuticas de lactobacillus salivarus ls01 22775 | |
DK1824500T3 (da) | Probiotisk lactobacillus-stamme til forbedret vaginal sundhed | |
BRPI1014304A2 (pt) | bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes | |
WO2009112361A3 (en) | Synbiotic mixture | |
AP2957A (en) | New antibodies specific of the Beta-amyloid peptides and their uses as diagnostic agents or drugs | |
BRPI0817905A2 (pt) | Utilização de uma cepa de bifidobacterium, para o preparo de uma composição destinada à prevenção e/ou ao tratamento de manifestações do tipo alérgicas | |
EP2576587A4 (en) | MUTANT NGAL PROTEINS AND USES THEREOF | |
DK2802333T3 (da) | Lactobacillus rhamnosus og Bifidobacterium animalis subsp. lactis til anvendelse til forebyggelse eller behandling af øvre luftvejsinfektioner | |
ATE421572T1 (de) | Neue stämme von lactobacillus helveticus | |
BRPI0913297A2 (pt) | composição, farmacêutica, uso de uma composição, e, kit terapêutico. | |
ATE530070T1 (de) | Verwendung von lactobacillus casei zur verstärkung der schutzwirkung der grippeimpfung | |
BR112014002911A2 (pt) | linhagem de l. bulgaricus capaz de inibir a adesão de linhagens de h. pylori a células epiteliais | |
ATE423840T1 (de) | Neue stämme von lactobacillus helveticus | |
IL210068A0 (en) | Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains | |
AP2008004650A0 (en) | Novel enterococcus and streptococcus strains and bacteriocins | |
BRPI0909760A2 (pt) | Cepa de lactobacillus rhamnosus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: DUPONT NUTRITION BIOSCIENCES APS (DK) |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |